CrushSCI.com
CrushSCI reveals real review times for each journal, giving authors transparent guidance for submission. As AI makes publishing increasingly challenging, the platform helps authors improve submission efficiency. Contact us if you need assistance.
Neurology-Neuroimmunology & Neuroinflammation 临时占位封面 Medicine
Back to journal directory

Review Cycle Records

Neurology-Neuroimmunology & Neuroinflammation

Ovid Technologies (Wolters Kluwer) - American Academy of Neurology SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
146.2Average days
117Median days
107Fastest days
265Longest days
1552025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

117 days

Clear Positive MOG Antibodies in Adults With Multiple Sclerosis Features

Authors
Jeanne Garcia; Natalia Shor; Clemence Boutiere; Julie Pique; Marine Boudot De La Motte; Maxime Guillaume; Adrien Delourme; Helene Zephir; Jonathan Ciron; Clarisse Carra-Dalliere; Pauline Buissonnière; Nicolas Mélé; Jennifer Aboab; Mikael Cohen; Adrien Wang; Justine Couturier; Diana Rusu; Eric Thouvenot; David Axel Laplaud; Aurélie Ruet; Bertrand Bourre; Françoise Durand-Dubief; Lakhdar Benyahya; Nicolas Collongues; Laure Michel; Romain Deschamps; Caroline Papeix; Bertrand Audoin; Bruno Stankoff; Valerie Touitou; Catherine Vignal Clermont; Delphine Sterlin; Romain Marignier; Elisabeth Maillart; for the NOMADMUS study groupShow moreShow less
Affiliations
1. Department of Neurology, centre de ressources et de compétences SEP–Paris, Pitié-Salpêtrière University Hospital, AP-HP, France;; 2. Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM)–Paris, France;; 3. Paris-Brain Institute (ICM), Paris Brain Institute's Data and Analysis Core, Pitié-Salpêtrière hospital, Sorbonne université, Inserm U1127, CNRS UMR 7225, France;; 4. Department of NeuroRadiology, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France;; 5. Marseille University Hospital Timone, Neurology, France;; 6. Service de Neurologie, Sclerose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hospices Civils de Lyon, Bron, France;; 7. Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle (MIRCEM), Service de neuro-inflammation, Hospices Civils de Lyon, France;; 8. Department of neurology, Rothschild Foundation Hospital, University Paris-Cité, Paris, France;; 9. Department of Neurology, CHU ROUEN, F-76000, Rouen, France;; 10. Department of neurology, Centre Hospitalier Princesse Grace, Monaco;; 11. University of Lille, Neurology, Inserm U 1172, CHU of Lille, France;; 12. Department of Neurology, University Hospital of Toulouse, CRC-SEP, France;; 13. University Toulouse III, Infinity, INSERM UMR1291–CNRS UMR5051, France;; 14. Montpellier University Hospital, Neurology, Montpellier, France;; 15. Department of Neurology, MS center, University Hospital of Bordeaux, France;; 16. Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Turc team, France;; 17. Department of Neurology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France;; 18. Department of Internal Medecine, 15-20 hospital, Paris, France;; 19. CRCSEP Neurologie Pasteur 2, CHU de Nice, Université Cote d'Azur, UMR2CA (URRIS), France;; 20. Department of neurology, Foch Hospital, Paris, France;; 21. Centre hospitalier universitaire de Nantes, Neurology Department, CR2TI-Inserm U1064, Nantes Université, CIC1413, France;; 22. IGF, Univ Montpellier, CNRS, INSERM, Service de Neurologie, CHU Nimes, France;; 23. Neurocentre Magendie, Bordeaux University, INSERM U1215, France;; 24. Université de Lyon, Université Claude Bernard Lyon 1, France;; 25. CHU Strasbourg, Neurology and CIC 1434, France;; 26. Neurology Department, Clinical Neuroscience Centre, CIC_P1414 INSERM, MOBIDIC _U1236, University Hospital, Rennes, France;; 27. Ophthalmology Department, Sorbonne Université, AP-HP, Pitie-Salpetriere University Hospital, Paris, France;; 28. Ophthalmology Department, Rothschild Foundation Hospital, University Paris-Cité, France; and; 29. Immunology Department, Sorbonne Université, AP-HP, Pitie-Salpetriere University Hospital, Paris, France.Show moreShow less
Official full-text evidence DOI Publisher page
265 days

Metabolomic Profiles Associated With Disease Severity in Multiple Sclerosis

Authors
Fatemeh Siavoshi; Dimitrios C. Ladakis; Larissa Jank; Blake E. Dewey; Angeliki G. Filippatou; Matthew D. Smith; Jerry L. Prince; Elias S. Sotirchos; Shiv Saidha; Ellen M. Mowry; Peter A. Calabresi; Kathryn C. Fitzgerald; Pavan BhargavaShow moreShow less
Affiliations
1. Division of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD;; 2. Department of Epidemiology, Johns Hopkins University School of Public Health, Baltimore, MD; and; 3. Image Analysis and Communications Laboratory, Johns Hopkins University, Baltimore, MD.Show moreShow less
Official full-text evidence DOI Publisher page
107 days

Application of Optic Neuritis Diagnostic Criteria in Autoimmune Paraneoplastic CRMP5 Optic Neuropathy and Development of the “CRMP” Score

Authors
Alessandro Dinoto; Devon A. Cohen; Laura Cacciaguerra; Nanthaya Tisavipat; Stephanie B. Syc-Mazurek; Vanda A. Lennon; M. Tariq Bhatti; Deena A. Tajfirouz; Kevin D. Chodnicki; Sean J. Pittock; Eoin P. Flanagan; John J. ChenShow moreShow less
Affiliations
1. Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN;; 2. Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy;; 3. Department of Ophthalmology, Cleveland Clinic Foundation, OH;; 4. Department of Ophthalmology, Mayo Clinic, Rochester, MN;; 5. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and; 6. Department of Ophthalmology, The Permanente Medical Group, Kaiser Permanente-Northern California, Roseville, CA.Show moreShow less
Official full-text evidence DOI Publisher page
125 days

Disease Activity During Pregnancy and Postpartum in Women With Multiple Sclerosis Treated With Ocrelizumab or Rituximab Before Pregnancy

Authors
Nadine Bast; Karen Dost-Kovalsky; Sabrina Haben; Laura Witt; Ralf Gold; Sandra Thiel; Kerstin HellwigShow moreShow less
Affiliations
1. Department of Neurology, St. Josef-Hospital - Katholisches Klinikum Bochum, Ruhr University Bochum, Germany;; 2. Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-Universität Düsseldorf, Germany; and; 3. Institute of Social Medicine and Epidemiology, Nursing Research Unit, University of Lübeck, Germany.Show moreShow less
Official full-text evidence DOI Publisher page
117 days

Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody–Positive NMOSD

Authors
Dean M. Wingerchuk; Jeffrey L. Bennett; Achim Berthele; Stacey L. Clardy; Ho Jin Kim; Jin Nakahara; Jérôme de Sèze; Makoto Kinoshita; Breni Sharma; Cassandra L. Uchida; Ruba Deeb Bou-Chahine; Becky Parks; Kerstin Allen; Jeannette N. Stankowski; Sean J. PittockShow moreShow less
Affiliations
1. Neurology, Mayo Clinic, Phoenix, AZ;; 2. Neurology, University of Colorado, Aurora, CO;; 3. Neurology, Technical University of Munich, Germany;; 4. Neurology, University of Utah Health, Salt Lake City;; 5. Neurology, National Cancer Center, Goyang, Republic of Korea;; 6. Neurology, Keio University School of Medicine, Tokyo, Japan;; 7. Neurology, CHU de Strasbourg, France;; 8. Neurology, The University of Osaka Graduate School of Medicine, Japan;; 9. NHO Osaka Toneyama Medical Center, Toyonaka, Japan;; 10. Acumetis, Toronto, ON, Canada;; 11. Alexion, AstraZeneca Rare Disease, Boston, MA; and; 12. Alexion, AstraZeneca Rare Disease, Rochester, MN.Show moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.